American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$310M |
| 2 |
AbbVie
ABBV
|
+$279M |
| 3 |
L3Harris
LHX
|
+$251M |
| 4 |
VeriSign
VRSN
|
+$238M |
| 5 |
Jacobs Solutions
J
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$510M |
| 2 |
Texas Instruments
TXN
|
+$504M |
| 3 |
Adobe
ADBE
|
+$416M |
| 4 |
PayPal
PYPL
|
+$378M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.49% |
| 2 | Financials | 15% |
| 3 | Healthcare | 14.78% |
| 4 | Consumer Discretionary | 11.1% |
| 5 | Industrials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Rollins
ROL
$17.4B
| $3.59M | ﹤0.01% |
102,799
+85,768
| +504% | +$2.94M |
|
1227
Plains GP Holdings
PAGP
$5.07B
| $3.59M | ﹤0.01% |
347,518
+290,712
| +512% | +$3.34M |
|
1228
Qualys
QLYS
$6.51B
| $3.58M | ﹤0.01% |
28,416
+3,349
| +13% | +$439K |
|
1229
Banco Santander
SAN
$212B
| $3.57M | ﹤0.01% |
1,275,371
+264,918
| +26% | +$809K |
|
1230
Factset
FDS
$9.97B
| $3.56M | ﹤0.01% |
9,258
+6,012
| +185% | +$2.35M |
|
1231
Targa Resources
TRGP
$58.9B
| $3.55M | ﹤0.01% |
59,435
-657,678
| -92% | -$47.2M |
|
|
AEL
1232
DELISTED
American Equity Investment Life Holding Company
AEL
| $3.54M | ﹤0.01% |
96,785
-190,700
| -66% | -$7.26M |
|
1233
CME Group
CME
$96.1B
| $3.53M | ﹤0.01% |
17,262
+2,290
| +15% | +$485K |
|
1234
New Jersey Resources
NJR
$5.65B
| $3.53M | ﹤0.01% |
79,244
+65,188
| +464% | +$2.93M |
|
1235
Financial Institutions
FISI
$826M
| $3.49M | ﹤0.01% |
134,070
+17,376
| +15% | +$483K |
|
1236
Booz Allen Hamilton
BAH
$9.39B
| $3.49M | ﹤0.01% |
38,597
+325
| +0.8% | +$27.7K |
|
|
TDCX
1237
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $3.47M | ﹤0.01% |
375,506
| – | – |
|
1238
Weatherford International
WFRD
$6.79B
| $3.46M | ﹤0.01% |
163,418
+78,276
| +92% | +$2.49M |
|
1239
10x Genomics
TXG
$7.43B
| $3.45M | ﹤0.01% |
76,214
-42,537
| -36% | -$2.21M |
|
1240
Alcoa
AA
$13.4B
| $3.44M | ﹤0.01% |
75,580
-262,851
| -78% | -$17.1M |
|
1241
iShares MSCI India Small-Cap ETF
SMIN
$772M
| $3.43M | ﹤0.01% |
70,353
-9,656
| -12% | -$512K |
|
1242
Ethan Allen Interiors
ETD
$578M
| $3.43M | ﹤0.01% |
169,776
+40,960
| +32% | +$968K |
|
1243
American Century Mid Cap Growth Impact ETF
MID
$106M
| $3.43M | ﹤0.01% |
87,226
-29,975
| -26% | -$1.29M |
|
1244
Genuine Parts
GPC
$18.6B
| $3.42M | ﹤0.01% |
25,688
+824
| +3% | +$110K |
|
1245
Aon
AON
$75.1B
| $3.41M | ﹤0.01% |
12,653
-3,516
| -22% | -$1.01M |
|
1246
NNN REIT
NNN
$8.87B
| $3.41M | ﹤0.01% |
79,328
+11,072
| +16% | +$487K |
|
|
ITOS
1247
DELISTED
iTeos Therapeutics
ITOS
| $3.4M | ﹤0.01% |
165,220
+43,825
| +36% | +$1.04M |
|
1248
Hawkins
HWKN
$2.73B
| $3.4M | ﹤0.01% |
94,233
-1,417
| -1% | -$53.6K |
|
1249
Fortuna Silver Mines
FSM
$3.2B
| $3.39M | ﹤0.01% |
1,194,485
+252,117
| +27% | +$878K |
|
1250
Omnicom Group
OMC
$24B
| $3.38M | ﹤0.01% |
53,213
-133,540
| -72% | -$9.88M |
|
Similar funds
American Century Companies's Q2 2022 Portfolio in Review
As of Q2 2022, American Century Companies held 2,437 positions worth $122B, down 16% from $146B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
American Century Companies's Q2 2022 filing shows 146 new, 1,442 increased, 596 reduced and 133 closed positions. Its largest new stake was Maravai LifeSciences: 2,396,740 shares worth $68.1M. The largest sale was Meta Platforms (Facebook), an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2022 buy was Maravai LifeSciences: 2,396,740 shares worth $68.1M.
- American Century Companies added most to NVIDIA in Q2 2022, an estimated $310M increase.
- American Century Companies's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $510M.
- American Century Companies fully exited iShares Russell Mid-Cap Value ETF in Q2 2022, selling an estimated $278M.
- American Century Companies's ten largest holdings make up 21% of its $122B portfolio in Q2 2022.
- American Century Companies opened 146 new positions and closed 133 in Q2 2022.
- American Century Companies's portfolio value fell 16% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q2 2022, filed 12 Aug 2022.